Ronit Simantov - 08 Feb 2023 Form 4 Insider Report for Gamida Cell Ltd.

Role: CMO & Chief Scientific Officer
Signature: /s/ Joshua F. Patterson, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 08 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 10 Feb 2023, 18:59:25 UTC
Previous filing: 10 Feb 2023
Next filing: 20 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GMDA	Ordinary Shares	Award	$0	+58,100	+49%	$0.000000	175,577	08 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GMDA	Employee Share Option (Right to Buy)	Award	$0	+116,340		$0.000000	116,340	08 Feb 2023	Ordinary Shares	116,340	$1.59	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted share unit award, and shall vest with respect to 33% of the RSUs, on each of August 8, 2023 and August 8, 2024, respectively, and with respect to 34% of the RSUs, on August 8, 2025. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date.
F2	33% of the shares subject to the option award shall vest on each of August 8, 2023 and August 8, 2024, respectively, and 34% of the shares subject to the option award shall vest on August 8, 2025, subject to the Reporting Person's continuous service through such vesting date.